Literature DB >> 7501376

Intractable epistaxis: transantral ligation vs. embolization: efficacy review and cost analysis.

E B Strong1, D A Bell, L P Johnson, J M Jacobs.   

Abstract

After posterior nasal packing, the two most common therapies for intractable epistaxis are transantral ligation of the internal maxillary artery and percutaneous embolization of the distal internal maxillary artery. However, optimal management of intractable posterior epistaxis remains controversial. We retrospectively reviewed the charts of 21 patients treated for intractable epistaxis and obtained data on presentation, risk factors, treatment, success rates, complications, and cost. Twelve patients received percutaneous embolization, five underwent transantral ligation, and four required both. The success rates for transantral ligation and percutaneous embolization were 89% and 94%, respectively. No mortality or serious morbidity occurred with either technique. A cost comparison revealed that transantral ligation was moderately less expensive than percutaneous embolization ($5941 vs. $6783). Although some authors advocate transantral ligation or percutaneous embolization as the procedure of choice for intractable epistaxis, a direct comparison of efficacy and cost reveals that they are comparable procedures with specific strengths and weaknesses. We present our experience and a review of the literature, highlighting the indications and advantages of each technique. We conclude that the choice of treatment modality should be based on the benefits of each procedure as it pertains to the specific needs of the individual patient.

Entities:  

Mesh:

Year:  1995        PMID: 7501376     DOI: 10.1016/S0194-59989570004-8

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   5.591


  12 in total

1.  Role of Endoscopic Internal Maxillary Artery Ligation in Intractable Idiopathic Epistaxis.

Authors:  Vivek Sasindran; Mithra Sara John
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-01-08

2.  Anatomical and surgical study of the sphenopalatine artery branches.

Authors:  Juan R Gras-Cabrerizo; Joan M Ademá-Alcover; Juan R Gras-Albert; Katarzyna Kolanczak; Joan R Montserrat-Gili; Rosa Mirapeix-Lucas; Francisco Sanchez Del Campo; Humbert Massegur-Solench
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-20       Impact factor: 2.503

Review 3.  Transcatheter embolization in the management of epistaxis.

Authors:  Gregory J Dubel; Sun Ho Ahn; Gregory M Soares
Journal:  Semin Intervent Radiol       Date:  2013-09       Impact factor: 1.513

4.  Bilateral tri-arterial embolization for the treatment of epistaxis.

Authors:  Qaisar A Shah
Journal:  J Vasc Interv Neurol       Date:  2008-10

Review 5.  Epistaxis: an update on current management.

Authors:  L E R Pope; C G L Hobbs
Journal:  Postgrad Med J       Date:  2005-05       Impact factor: 2.401

6.  Endoscopic Excision of Non-embolized Juvenile Nasopharyngeal Angiofibroma: Our Technique.

Authors:  Trichy Narayanan Janakiram; Shilpee Bhatia Sharma; Vidya Bhargavan Panicker
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2016-07-12

7.  Sphenopalatine-sphenopalatine anastomosis: a unique cause of intractable epistaxis, safely treated with microcatheter embolization: a case report.

Authors:  Tawakir Kamani; Simon Shaw; Ahmed Ali; George Manjaly; Martin Jeffree
Journal:  J Med Case Rep       Date:  2007-10-31

8.  Evaluation of Etiology and Treatment Methods for Epistaxis: A Review at a Tertiary Care Hospital in Central Nepal.

Authors:  Ramesh Parajuli
Journal:  Int J Otolaryngol       Date:  2015-08-09

Review 9.  Radiological diagnosis and management of epistaxis.

Authors:  Antonín Krajina; Viktor Chrobok
Journal:  Cardiovasc Intervent Radiol       Date:  2014-02       Impact factor: 2.740

10.  Pseudoaneurysm in the Internal Maxillary Artery Occurring After Endoscopic Sinus Surgery.

Authors:  Eun Jung Lee; Hye Jin Hwang; Kyung-Su Kim
Journal:  J Craniofac Surg       Date:  2016-06       Impact factor: 1.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.